| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 36 |
| 1 | METHOTREXATE | 17 |
| 2 | METHOTREXATE SODIUM | 17 |
| 3 | ASPIRIN | 16 |
| 4 | ASPIRIN 325 MG | 16 |
| 5 | ASPIRIN 81 MG | 16 |
| 6 | VALSARTAN | 16 |
| 7 | VALSARTAN ORAL | 14 |
| 8 | FUROSEMIDE | 12 |
| 9 | OMEPRAZOLE MAGNESIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 1 | GATIFLOXACIN | 2 | 0.0011 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 3 | HYALURONIC ACID | 1 | 0.0009 |
| 4 | DEFLAZACORT | 2 | 0.0008 |
| 5 | CEFADROXIL | 1 | 0.0005 |
| 6 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 7 | CERITINIB | 1 | 0.0004 |
| 8 | MIDAZOLAM HYDROCHLORIDE | 10 | 0.0004 |
| 9 | CALCITONIN SALMON | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 1 | Corticosteroid [EPC] | 23 |
| 2 | Benzodiazepine [EPC] | 22 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 18 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 12 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Calcium Channel Blocker [EPC] | 11 |
| 9 | Proton Pump Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Typical Antipsychotic [EPC] | 7 | 0.0003 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |
| 6 | Barbiturate [EPC] | 1 | 0.0001 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 18 | 0.0001 |